Total Human Eye-allotransplantation Innovation Advancement (THEIA)

Medicine and Dentistry

1. Allograft 100%
2. Ganglion 100%
3. Doctor of Philosophy 90%
4. Optic Nerve 72%
5. Necrosis 18%
6. Fluorescence Activated Cell Sorting 18%
7. Organ Transplantation 18%
8. Electrotherapy 18%
9. Surgical Technique 18%
10. Programmed Cell Death 18%
11. Small Interfering RNA 18%
12. Reinnervation 18%
13. Remyelination 18%
14. Axon 18%
15. Ischemia 9%
16. Immunosuppressive Treatment 9%
17. Axotomy 9%
18. Glia 9%
19. Craniofacial Surgery 9%
20. Ex Vivo 9%
21. Gene Therapy 9%
22. Receptor 9%
23. Reperfusion Injury 9%
24. Diencephalon 9%
25. Neurite Outgrowth 9%
26. Nerve Fiber Regeneration 9%
27. Preservation Solution 9%
28. Otorhinolaryngology 9%
29. Flow Cytometry 9%
30. Gene Expression 9%
31. Cell Growth 9%
32. Neurosurgery 9%
33. Graft Survival 9%
34. Electrophysiology 9%
35. RNA Sequence 9%
36. Organ Donor 9%
37. Synaptogenesis 9%
38. Microsurgery 9%
39. Apoptosis Inhibitor 9%
40. Immunology 9%
41. Ophthalmology 9%
42. Cell Viability 9%
43. Extracorporeal Membrane Oxygenation 9%
44. Contact Lens 9%
45. Human Pluripotent Stem Cell 9%
46. Minoxidil 9%
47. Gene Regulatory Network 9%
48. Pluripotent Stem Cell 9%
49. Synapsin I 9%
50. Optic Neuropathy 9%
51. Cytotechnology 9%
52. Biocompatible Material 9%
53. Inflammation 9%
54. Spatial Transcriptomics 9%